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Abstract

Background: Increased incidence of hypertension, non-insulin dependent diabetes (NIDDM) and
coronary heart disease often cluster in the same individuals and there have been speculations that a
common mechanism may be responsible for all of these pathological conditions. This risk factor
constellation, which is associated with an enhanced risk for cardiovascular disease, is sometimes
referred to as the ‘Insulin Resistance Syndrome”, ‘Syndrome X”, or the “Metabolic Syndrome”.
Aim: To find out the prevalence of Syndrome X in the population of patients coming to a preventive
health check clinic at a tertiary care teaching hospital in a megacity of the developing world.
Methods: A total of 270 patients, above the age of 40 years, who attended preventive health check
clinics of 2 Family Physicians at the Aga Khan University from January 1996 to July 1997 were
selected. Patients below 40 years were excluded from the study.
Results: The prevalence of Syndrome X, defined as association of obesity, NIDDM, hypertension,
raised LDL and raised triglycerides is 2.6% in patients above 40 years, who were screened in this study.
Conclusion: The significant prevalence of Syndrome X is alarming and we need to strengthen our
existing educational programs for prevention of obesity, increased physical activity and better control
of hypertension. When drugs are selected for pharmacological treatment, priority should be given to
those, which improve the insulin sensitivity index or are at least neutral in this respect (JPMA 49: 177,
1999).
Introduction
all of these pathological conditions. Obesity is one
Ageing is associated with increased incidence of component of a risk factor constellation that consists
of hypertension, non-insulin dependent diabetes (NIDDM) insulin resistance and / or hyperinsulinaemia, and coronary heart disease1. As these conditions often hypertension, dyslipidaemia
characterized by a low HDL cluster in the same individual, there have been cholesterol or raised LDLcholesterol levels and high speculations that a common mechanism is responsible for triglycerides
levels2.
This risk factor constellation, is associated with an enhanced risk for cardiovascular disease and is
sometimes referred to as the “Insulin Resistance Syndrome”, “Syndrome X”, or the “Metabolic
Syndrome”. Although the hyperinsulinaemia and insulin resistance associated with the syndrome X
appears to play a central role, the relationship between insulin and the other manifestations of the
syndrome have remained obscure3.
It is hyper-insulinaemia, with its complex array of adverse metabolic effects that has recently worried
physicians. Acceleration of atherosclerosis,, hypertension and worsening of the lipoprotein profile have
been cited as possible adverse effects of hyperinsulinaernia4. Currently available data and clinical
observations suggest that there is a pathogenetic relationship between hypertension, diabetes mellitus
and atherosclerosis, which together are components of Syndrome X, found predominantly in males5.
The hypothesis of insulin resistance leading to arterial hypertension is based on increased
sympathomimetic activity, sodium retention and trophic effects of insulin6.
Reduced vascularization of the skeletal muscles associated with insulin resistance leads to enhanced

development of hypertension with subsequent hypertrophy of the vascular wall and left ventricle
leading to the development of arteriosclerosis7.
Syndrome X has been defined in different ways. It was first described by Reaven as Reaven’s
Syndrome8, which included hyper-insulinaemia, glucose intolerance, hyperlipidaem ia, hypertension
and fibrinolytic impairment. Another name used is 5H Syndrome i.e., association of hyper- insulinism,
hyperglycemia (NIDDM), hyperlipoproteinaemia, hypertension, hirsutism and the polycystic ovary
syndrome9.
Syndrome X-plus is a newly suggested condition, which includes hyperuricemia as an additional
feature to Reavens components but does not include fibrinolytic impairment. For the purpose of this
study, Syndrome X has been defined as an association of hypertension, hyperglycemia (NIDDM),
obesity, low HDL and raised LDL4-6.
The hormonal and metabolic features of syndrome X suggest that Family Practitioners have an
important role to play in the preventive and curative aspects of hypertension and other associated
conditions which enhance the risk of cardio-vascular morbidity and mortality in the population.
According to a study covering 10.9% of the total population aged above 40 years, the prevalence of
Syndrome X characterized by presence of glucose intolerance, hypertension and hypertriglyceridemia
was
1 .6%10.
The objecives of this study were to find the prevalence of Syndrome X and look into factors associated
with it in patients presenting to a Screening Family Medicine Clinic.
Methodology
It was a retrospective cross-sectional study, including all patients above the age of 40 years attending
the Screening Family Medicine Clinics of two family physicians, at the Aga Khan University Hospital
Karachi. The data was gathered through the confidential records of patients coming to the clinic
between January 1996 and July 1997 (i.e., 18 months). For the purpose of this study, certain standard
values were used (Table 1).

Analysis
Data was entered and analyzed in the EPI-Info
program at the Family Medicine Division, Department of Community Health Sciences at the Aga Khan
University Hospital. Correlation of associated factors and other variables were analyzed with the help
of level of significance (pvalue).
Results
A total of 401 patients were seen from January 1996 till July 1997 at the Family Medicine Screening
clinics of 2 family practitioners at the Aga Khan University Hospital, out of which the data on 270
patients who were above the age of 40 years was collected and analyzed, as Syndrome X is seen in
ageing patients.

Table 2 shows few of the characteristics of the study patients. Raised BMI and dyslipidaemia were
present in more then the majority of patients, whereas presence of hypertension and hyperglycemia was
significant (Figure 1).

We correlated the relationship of CVA and IHD with respect to hypertension and found unexpectedly
that CVA was seen more in our non-hypertensive group (Table 3);

this could possibly be due to small sample size.
The prevalence of Syndrome X, defined as an association of obesity, NIDDM, hypertension, raised

LDL and raised triglycerides was found to be 2.6% in patients above the age of 40 (Figure 2).

Discussion
The relationship betwen obesity and cardiovascular disease is a matter of debate for many years.
Recent studies have demonstrated that obesity defined as body mass index of 25 kg/m2 or higher is
associated with an exponential increase of cardiovascular complications10. The effect is largely
mediated by the induction of established risk factors such as dyslipidaemia. hypertension and type 2
diabetes mellitus. Recently, there is a growing evidence that the occurrence of most complications of
obesity depends not only on the degree of overweight but also on the pattern of body fat distribution10.
Many data suggest that the anatomical localization of body fat is more important for the risk of
developing complications than the adipose tissue mass perse”.
The components of the metabolic Syndrome X are characterized by varying forms and degrees of
insulin resistance. It is assumed that insulin resistance, defined as diminished biological response to the
action of insulin, represents the primary defect or at least the common pathogenetic link between these
disturbances.
It is hyperinsulinaemia, with its complex array of adverse metabolic effects that has recently concerned
physicians. Acceleration of autheroscelerosis, hypertension and worsening of the lipoprotein profile
have been cited as possible adverse effects11. In this study, obesity and hyperlipidaemia was seen in
significant number of patients attending screening clinics (Figure 1). The hypotheses of insulin
resistance in the pathogenesis of arterial hypertension as part of the Syndrome X is based on
sympathomimetic, sodium retention and trophic effects of insulin8-10.
From the clinical aspects, this stimulating pathogenetic concepts within the framework of Syndrome X
makes it possible to use a more adequate approach to prevention and treatment not only of arterial
hypertension but also of associated phenomena which enhance the risk of cardiovascular morbidity and
mortality in the population. This shows the impact of dyslipidaemias and diabetes in making the
outcome worse.

Conclusion
This study has highlighted the prevalence of Syndrome X which is described as the constellation of
obesity, NIDDM, hypertension, raised LDL and raised triglycerides in a population of patients
presenting to a screening family medicine clinics at a city university hospital. The significant
prevalence of Syndrome X is alarming and we need to strengthen our existing health education
programs for prevention of obesity, increased activity, better control of hypertension and raised lipids.
When drugs are selected for pharmacological treatment in such cases, priority should be given to those
which improve the insulin sensitivity index (ACE-inhibitors, alpha blockers) or are at least neutral in
this respect (Ca antagonists, beta blockers with ISA). Drugs must not enhance associated
hyperlipoproteinaemia. A further study is planned for estimating the fasting levels of insulin on the
cases identified in the study.
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